bioAffinity receives Nasdaq delisting notice; equity of $1.44M below $2.5M minimum

bioAffinity Technologies, Inc.

Stockholders' equity was $1,439,404 as of March 31, 2025, well below the $2,500,000 minimum.
Company must submit a compliance plan by July 11, 2025 (45 days) to regain compliance.
If plan accepted, Nasdaq may grant up to 180-day extension from May 27, 2025.
Trading continues on Nasdaq Capital Market under BIAF and BIAFW symbols pending resolution.
This notice is separate from prior bid price deficiency notice received February 7, 2025.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.